Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Recommendations for the treatment of established fungal infections|
|Citation:||Internal Medicine Journal, 2008; 38(6):496-520|
|Publisher:||Blackwell Publishing Asia|
|K. A. Thursky, E. G. Playford, J. F. Seymour, T. C. Sorrell, D. H. Ellis, S. D. Guy, N. Gilroy, J. Chu and D. R. Shaw|
|Abstract:||Evidence-based guidelines for the treatment of established fungal infections in the adult haematology/oncology setting were developed by a national consensus working group representing clinicians, pharmacists and microbiologists. These updated guidelines replace the previous guidelines published in the Internal Medicine Journal by Slavin et al. in 2004. The guidelines are pathogen-specific and cover the treatment of the most common fungal infections including candidiasis, aspergillosis, cryptococcosis, zygomycosis, fusariosis, scedosporiosis, and dermatophytosis. Recommendations are provided for management of refractory disease or salvage therapies, and special sites of infections such as the cerebral nervous system and the eye. Because of the widespread use newer broad-spectrum triazoles in prophylaxis and empiric therapy, these guidelines should be implemented in concert with the updated prophylaxis and empiric therapy guidelines published by this group.|
|Keywords:||Antifungal therapy; invasive mould infections; candidiasis; aspergillosis; consensus guidelines|
|Description:||© 2008 The Authors Journal compilation. Copyright © 2008 John Wiley & Sons, Inc|
|Appears in Collections:||Molecular and Biomedical Science publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.